Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Revolution Medicines, Inc. - Common Stock
(NQ:
RVMD
)
36.76
+0.56 (+1.55%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Revolution Medicines, Inc. - Common Stock
< Previous
1
2
3
4
Next >
Revolution Medicines' Early-Data Validation For Cancer Program Wins Price Target Boost By This Analyst
February 28, 2023
Via
Benzinga
Dentsply Sirona, Chico's FAS, Kontoor Brands And Other Big Stocks Moving Higher On Tuesday
February 28, 2023
U.S. stocks traded lower, with the Dow Jones dropping more than 150 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023
February 28, 2023
Via
Benzinga
Revolution Medicines Earnings Preview
February 24, 2023
Via
Benzinga
Where Revolution Medicines Stands With Analysts
December 14, 2022
Via
Benzinga
Executives Buy More Than $12M Of 3 Stocks
March 22, 2022
Although US stocks closed mostly lower on Monday, there were a few notable insider trades.
Via
Benzinga
Insiders Buy More Than $19M Of 3 Stocks
March 10, 2022
Although US stocks closed sharply higher on Wednesday, there were a few notable insider trades.
Via
Benzinga
Earnings Scheduled For February 27, 2023
February 27, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
Via
Benzinga
Chefs' Warehouse, Chart Industries And Some Other Big Stocks Moving Lower On Thursday
December 08, 2022
U.S. stocks traded higher, with the Dow Jones jumping over 200 points on Thursday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Revolution Medicines Regains Global Rights To Mid-Stage Cancer Program As Sanofi Terminates Collaboration
December 08, 2022
Via
Benzinga
Revolution Medicines Reports Third Quarter 2022 Financial Results and Update on Corporate Progress
November 07, 2022
From
Revolution Medicines, Inc.
Via
GlobeNewswire
LegalZoom.com, Toast And Some Other Big Stocks Moving Higher On Friday
August 12, 2022
WeTrade Group, Inc. (NASDAQ: WETG) jumped 46% to $20.56 after the company announced it entered into a sales agreement with Parkway Medical Limited to sell monkeypox virus test kits and antigen tests...
Via
Benzinga
Earnings Scheduled For November 7, 2022
November 07, 2022
Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million.
Via
Benzinga
Earnings Outlook For Revolution Medicines
August 08, 2022
Revolution Medicines (NASDAQ:RVMD) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement.
Via
Benzinga
$10 Million Bet On This Financial Services Stock? 3 Stocks Insiders Are Buying
July 26, 2022
Although US stocks closed mixed on Monday, there were a few notable insider trades.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022
October 21, 2022
Upgrades
Via
Benzinga
Revolution Medicines Stock Is Getting Hammered: Here's Why
July 20, 2022
Revolution Medicines Inc (NASDAQ: RVMD) shares are trading lower by 11.25% to $21.82 Wednesday morning after the company announced the pricing of its underwritten public offering of 11,500,000 shares...
Via
Benzinga
The Daily Biotech Pulse: CDC AdComm Backs Novavax COVID-19 Vaccine, European Approval For PTC Therapeutics' Gene Therapy, Merck's Keytruda Flunks In Head, Neck Cancer Study
July 20, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Scheduled For August 9, 2022
August 09, 2022
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 20, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
July 20, 2022
Investors ready to start trading early this morning will want to check out the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
July 19, 2022
Gainers Talis Biomedical (NASDAQ:TLIS) shares moved upwards by 10.6% to $0.94 during Tuesday's after-market session. The company's market cap stands at $25.0 million.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022
May 20, 2022
Upgrades
Via
Benzinga
Earnings Scheduled For May 9, 2022
May 09, 2022
Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.
Via
Benzinga
Revolution Medicines's Earnings Outlook
May 06, 2022
Revolution Medicines (NASDAQ:RVMD) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
7 Stocks That Insiders Are Buying Now. Should You?
March 31, 2022
These stocks have seen big insider buying, but you may want to consider other factors before following suit.
Via
InvestorPlace
Children's Place And 2 Other Stocks Bought By Insiders
March 25, 2022
Although US stock futures traded higher this morning on Friday, there were a few notable insider trades.
Via
Benzinga
Insiders Buy More Than $3B Of 4 Stocks
March 07, 2022
Although US stock futures traded lower this morning amid rising Russia-Ukraine concerns, there were a few notable insider trades.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022
March 01, 2022
Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ:RVMD) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71,...
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.